Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scandinavian Medical Solutions – Præsentation af nedjusterede forventninger til 2024/25 og Q&A

By HC Andersen Capital
Scandinavian Medical Solutions

Scandinavian Medical Solutions har nedjusteret forventningerne til regnskabsåret 2024/25 som følge af den geopolitiske situation og økonomiske usikkerhed. Selskabet forventer nu en omsætning på mellem DKK 200-240 mio. (tidligere DKK 240-270 mio.) og EBITDA på mellem DKK 11-15 mio. (tidligere DKK 24-29 mio.).

Både den 24. marts kl. 11.00 og den 27. marts kl. 14:00 kan du møde og stille spørgsmål til Scandinavian Medical Solutions’ ledelse, der vil præsentere de nye forventninger til regnskabsåret 2024/25 og svare på spørgsmål.

Disclaimer: HC Andersen Capital modtager betaling fra Scandinavian Medical Solutions for en Corporate Visibility/Digital IR abonnementsaftale. /Kasper Lihn 15.46, 21. marts 2025.

Recent videos

Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-16 08:30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
2025-12-15 13:00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-15 13:00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.